Re: [177Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre,Single-arm,Phase 2 Study
1. Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium;2. Department of Radiation Oncology and Experimental Cancer Research, Ghent University, Ghent, Belgium